Earnings Call · Q4 FY2022·2023-03-01

Q4 22EPS +7.41%·Rev n/aQ3 22EPS +19.39%·Rev n/aQ2 22EPS +13.59%·Rev n/aQ1 22EPS -0.96%·Rev n/a⚠ consensus missing

RHYTHM PHARMACEUTICALS, INC. RYTM

+6.3%1d on move date+6.7% vs SPY3d−10.4%5d−10.8%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RYTM calls or request research access.

More RYTM calls Browse calls Request research access